ADMA Biologics, Inc.ADMANASDAQ
Loading
Stockholders Equity Over TimeExpanding
Percentile Rank100
3Y CAGR+46.4%
5Y CAGR+40.2%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
+46.4%/yr
vs +66.5%/yr prior
5Y CAGR
+40.2%/yr
Recent acceleration
Acceleration
-20.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $477.32M | +36.8% |
| 2024 | $349.02M | +158.1% |
| 2023 | $135.21M | -11.0% |
| 2022 | $151.97M | +7.7% |
| 2021 | $141.17M | +60.0% |
| 2020 | $88.25M | +236.9% |
| 2019 | $26.19M | +32.5% |
| 2018 | $19.77M | -51.0% |
| 2017 | $40.33M | +1004.9% |
| 2016 | $-4.46M | - |